TY - JOUR
T1 - Alcohol consumption and heart failure: a dose-response meta-analysis
AU - Wong, Bethany
AU - Ryan, Cristin
AU - Fagbamigbe, Adeniyi
AU - Bray, Jonathan JH
AU - McNamee, Bernard
AU - Niranjan, Vikram
AU - Zhou, Shuaiwei
AU - Bogdanet, Delia
AU - Reddin, Catriona
AU - McDonald, Ken
AU - Ledwidge, Mark
N1 - Publisher Copyright:
Copyright © 2024 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
PY - 2024/8/9
Y1 - 2024/8/9
N2 - Objectives: This is a protocol for a Cochrane Review (prototype). The objectives are as follows:. Main objective To assess the effects of alcohol consumption on the progression to symptomatic (stage C) heart failure in people at risk for heart failure (stage A) or in people with pre-heart failure (stage B). Secondary objectives To assess the effects of alcohol consumption on progression of left ventricular dysfunction in people with stage A or stage B heart failure. We will assess the effect of alcohol consumption on the development of heart failure with reduced ejection fraction, mildly reduced ejection fraction, and preserved ejection fraction. We also aim to evaluate the effects of alcohol consumption on the development of symptomatic (stage C) heart failure over the short, medium and long term.
AB - Objectives: This is a protocol for a Cochrane Review (prototype). The objectives are as follows:. Main objective To assess the effects of alcohol consumption on the progression to symptomatic (stage C) heart failure in people at risk for heart failure (stage A) or in people with pre-heart failure (stage B). Secondary objectives To assess the effects of alcohol consumption on progression of left ventricular dysfunction in people with stage A or stage B heart failure. We will assess the effect of alcohol consumption on the development of heart failure with reduced ejection fraction, mildly reduced ejection fraction, and preserved ejection fraction. We also aim to evaluate the effects of alcohol consumption on the development of symptomatic (stage C) heart failure over the short, medium and long term.
UR - http://dx.doi.org/10.1002/14651858.cd015398
U2 - 10.1002/14651858.cd015398
DO - 10.1002/14651858.cd015398
M3 - Article
SN - 1465-1858
VL - 2024
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
IS - 8
M1 - CD015398
ER -